Bloomberg Law
Free Newsletter Sign Up
Login
BROWSE
Bloomberg Law
Welcome
Login
Advanced Search Go
Free Newsletter Sign Up

Indivior Plunges on U.S. Charges Against Opioid Treatment (2)

April 10, 2019, 1:46 PM

Indivior Plc plummeted to an all-time low after U.S. prosecutors said the U.K. drugmaker deceived doctors about its addiction treatment’s dangers, fueling a deadly epidemic of opioid abuse.

Indivior misled doctors and government health programs into believing that the drug, Suboxone Film, was safer and less likely to be abused than rivals, the Justice Department said in a statement April 9. The company’s stock fell as much as 75 percent in London, shriveling its market value to 204 million pounds ($267 million).

Prosecutors’ decision marks a new twist in the thousands of lawsuits filed against opioid manufacturers, engulfing the Slough, ...